Abdominal Imaging

, Volume 38, Issue 6, pp 1431–1446

Imaging treated prostate cancer

  • P. J. L. De Visschere
  • H. A. Vargas
  • P. Ost
  • G. O. De Meerleer
  • G. M. Villeirs
Article

DOI: 10.1007/s00261-013-9998-3

Cite this article as:
De Visschere, P.J.L., Vargas, H.A., Ost, P. et al. Abdom Imaging (2013) 38: 1431. doi:10.1007/s00261-013-9998-3

Abstract

In patients with a clinical suspicion of recurrence after treatment for prostate cancer, imaging can be used to distinguish between local recurrence and metastatic disease. Multiparametric magnetic resonance imaging (mpMRI) of the prostate may be a valuable imaging modality for the detection and localization of local recurrence in patients treated for prostate cancer. In mpMRI, morphological T2-weighted images are combined with functional MRI techniques including diffusion-weighted imaging, dynamic contrast-enhanced imaging, and magnetic resonance spectroscopic imaging to improve accuracy. In this paper, the current status of imaging techniques used to detect and to localize tumor recurrence in patients treated for prostate cancer will be reviewed, with emphasis on mpMRI for local prostate cancer recurrence.

Keywords

ProstateImagingCancerRecurrenceMultiparametric MRI

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • P. J. L. De Visschere
    • 1
  • H. A. Vargas
    • 2
  • P. Ost
    • 3
  • G. O. De Meerleer
    • 3
  • G. M. Villeirs
    • 1
  1. 1.Department of RadiologyGhent University HospitalGhentBelgium
  2. 2.Department of RadiologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  3. 3.Department of Radiation OncologyGhent University HospitalGhentBelgium